Radiation Dosimetry and Biodistribution of the TSPO Ligand C-11-DPA-713 in Humans

Department of Radiology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Journal of Nuclear Medicine (Impact Factor: 5.56). 02/2012; 53(2):330-5. DOI: 10.2967/jnumed.111.094565
Source: PubMed

ABSTRACT Whole-body PET/CT was used to characterize the radiation dosimetry of (11)C-DPA-713, a specific PET ligand for the assessment of translocator protein.
Six healthy control subjects, 3 men and 3 women, underwent whole-body dynamic PET scans after bolus injection of (11)C-DPA-713. Subjects were scanned from head to mid thigh with 7 passes performed, with a total PET acquisition of approximately 100 min. Time-activity curves were generated in organs with visible tracer uptake, and tissue residence times were calculated. Whole-body dosimetry was calculated using OLINDA 1.1 software, assuming no voiding.
The absorbed dose is highest in the lungs, spleen, kidney, and pancreas. The lungs were determined to be the dose-limiting organ, with an average absorbed dose of 2.01 × 10(-2) mSv/MBq (7.43 × 10(-2) rem/mCi). On the basis of exposure limits outlined in the U.S. Food and Drug Administration Code of Federal Regulations (21CFR361.1), the single-dose limit for (11)C-DPA-713 radiotracer injection is 2,487.6 MBq (67.3 mCi).
(11)C-DPA-713 has an uptake pattern that is consistent with the biodistribution of translocator protein and yields a dose burden that is comparable to that of other (11)C-labeled PET tracers.

Download full-text


Available from: Christopher J Endres, Jul 03, 2015
1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A practical, multigram approach to the 2-(2-(4-alkoxyphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3- yl)acetamide (DPA) class of ligands targeting the translocator protein (TSPO) is described. This synthetic route offers several improvements over all previously described sequences, including the isolation of intermediates without resort to chromatography. The common precursor to the DPA class of high affinity TSPO ligands, N,N-diethyl-2-(2-(4-hydroxyphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide, was produced in 40% yield over six steps, and was cleanly alkylated to give multigram quantities of several DPA analogues in 90–96% yield after recrystallization.
    Tetrahedron Letters 07/2012; 53(29):3780-3783. DOI:10.1016/j.tetlet.2012.05.044 · 2.39 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background. Increased expression of the translocator protein (TSPO) is a feature of microglial and macrophage activation. Since activated macrophages are key components of tuberculosis (TB)-associated inflammation, we evaluated radioiodinated DPA-713, a synthetic ligand of TSPO, for in vivo imaging of host response.Methods. Mice were aerosol-infected with Mycobacterium tuberculosis and evaluated using whole-body [(125)I]iodo-DPA-713 single photon emission computed tomography (SPECT). Ex vivo biodistribution and correlative immunofluorescence studies were also performed.Results. [(125)I]Iodo-DPA-713-SPECT imaging clearly delineated TB-associated pulmonary inflammation in live animals. Biodistribution studies confirmed radiotracer specificity for inflamed pulmonary tissues. Immunofluorescence studies demonstrated that TSPO is highly expressed in CD68+ macrophages and phagocytic cells within TB lesions, and that [(125)I]DPA-713 specifically accumulates within these cells. Co-administration of excess unlabelled DPA-713 abrogated both the SPECT and ex vivo fluorescence signals. Lesion-specific signal-to-noise ratios were significantly higher with [(125)I]iodo-DPA-713-SPECT (4.06±0.52) versus [(18)F]fluorodeoxyglucose (FDG)-positron emission tomography (PET) (2.00±0.28) performed in the same mice (P=0.004).Conclusion. [(125)I]Iodo-DPA-713 accumulates specifically in TB-associated inflammatory lesions by selective retention within macrophages and phagocytic cells. [(125)I]Iodo-DPA-713-SPECT provides higher lesion-specific signal-to-noise ratios than [(18)F]FDG-PET imaging, and may prove to be a more specific biomarker to monitor TB disease in situ.
    The Journal of Infectious Diseases 07/2013; DOI:10.1093/infdis/jit331 · 5.78 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Myocarditis is more severe in men than in women and difficult to diagnose due to a lack of imaging modalities that directly detect myocardial inflammation. Translocator protein 18 kDa (TSPO) is used extensively to image brain inflammation due to its presence in CD11b(+) brain microglia. In this study, we examined expression of TSPO and CD11b in mice with coxsackievirus B3 (CVB3) myocarditis and biopsy sections from myocarditis patients in order to determine if it could be used to image myocarditis. We found that male mice with CVB3 myocarditis upregulated more genes associated with TSPO activation than female mice. TSPO expression was increased in the heart of male mice and men with myocarditis compared with female subjects due to testosterone, where it was expressed predominantly in CD11b(+) immune cells. We show that TSPO ligands detect myocardial inflammation using microSPECT, with increased uptake of [(125)I]-IodoDPA-713 in male mice with CVB3 myocarditis compared with undiseased controls.
    Journal of Cardiovascular Translational Research 01/2014; 7(2). DOI:10.1007/s12265-013-9538-0 · 2.69 Impact Factor